Clarence J. Peters
#115,941
Most Influential Person Now
Clarence J. Peters's AcademicInfluence.com Rankings
Clarence J. Petersphilosophy Degrees
Philosophy
#5035
World Rank
#7742
Historical Rank
Logic
#2380
World Rank
#3362
Historical Rank
Clarence J. Petersbiology Degrees
Biology
#6708
World Rank
#9482
Historical Rank
Virology
#138
World Rank
#143
Historical Rank
Download Badge
Philosophy Biology
Clarence J. Peters's Degrees
- Doctorate Medicine Johns Hopkins University
Why Is Clarence J. Peters Influential?
(Suggest an Edit or Addition)Clarence J. Peters's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Nipah virus: a recently emergent deadly paramyxovirus. (2000) (1138)
- Arenaviridae: The viruses and their replication (2001) (1070)
- Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. (1993) (1038)
- Hemorrhagic fever viruses as biological weapons: medical and public health management. (2002) (671)
- Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. (1999) (662)
- The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. (1996) (549)
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus (2012) (496)
- The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. (1999) (472)
- Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. (1999) (456)
- Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations (2010) (433)
- Hantavirus Pulmonary Syndrome: A Clinical Description of 17 Patients with a Newly Recognized Disease (1994) (403)
- Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. (1999) (399)
- Preliminary report: isolation of Ebola virus from monkeys imported to USA (1990) (377)
- Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. (1999) (372)
- Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. (1999) (359)
- Experimental inoculation of plants and animals with Ebola virus. (1996) (352)
- Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus (2007) (349)
- The Ecology and Evolutionary History of an Emergent Disease: Hantavirus Pulmonary Syndrome (2002) (333)
- An Outbreak of Rift Valley Fever in Northeastern Kenya, 1997-98 (2002) (315)
- Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. (1999) (299)
- Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection (1999) (289)
- Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. (1999) (278)
- Genetic Diversity among Lassa Virus Strains (2000) (276)
- Markedly elevated levels of interferon (IFN)-γ, IFN-α, interleukin (IL)-2, IL-10, and tumor necrosis factor-α associated with fatal Ebola virus infection (1999) (273)
- Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. (1985) (265)
- An introduction to Ebola: the virus and the disease. (1999) (255)
- Long-term studies of hantavirus reservoir populations in the southwestern United States: a synthesis. (1999) (251)
- ELISA for the detection of antibodies to Ebola viruses. (1999) (251)
- Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. (1999) (251)
- Methods for trapping and sampling small mammals for virologic testing (1995) (244)
- Syndromic Surveillance and Bioterrorism-related Epidemics (2003) (235)
- Guidelines for Working with Rodents Potentially Infected with Hantavirus (1995) (231)
- Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. (1998) (229)
- An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia. (1997) (226)
- Severe Acute Respiratory Syndrome (SARS) Coronavirus-Induced Lung Epithelial Cytokines Exacerbate SARS Pathogenesis by Modulating Intrinsic Functions of Monocyte-Derived Macrophages and Dendritic Cells (2008) (223)
- Rescue of Infectious Rift Valley Fever Virus Entirely from cDNA, Analysis of Virus Lacking the NSs Gene, and Expression of a Foreign Gene (2006) (222)
- Biochemical Analysis of the Secreted and Virion Glycoproteins of Ebola Virus (1998) (219)
- A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit. (1999) (215)
- Severe Acute Respiratory Syndrome Coronavirus Infection of Mice Transgenic for the Human Angiotensin-Converting Enzyme 2 Virus Receptor (2006) (215)
- Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. (1997) (213)
- Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. (1997) (205)
- An outbreak of hantavirus pulmonary syndrome, Chile, 1997. (1998) (202)
- Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. (1997) (200)
- Rift Valley Fever Virus NSs Protein Promotes Post-Transcriptional Downregulation of Protein Kinase PKR and Inhibits eIF2α Phosphorylation (2009) (199)
- Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. (1996) (195)
- Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. (1993) (195)
- Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. (1999) (194)
- Transmission of Ebola Viruses: What We Know and What We Do Not Know (2015) (191)
- An outbreak of hantavirus pulmonary syndrome in western Paraguay. (1997) (191)
- Using remotely sensed data to identify areas at risk for hantavirus pulmonary syndrome. (2000) (190)
- Laguna Negra virus associated with HPS in western Paraguay and Bolivia. (1997) (188)
- Experimental studies of arenaviral hemorrhagic fevers. (1987) (185)
- Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. (1996) (184)
- NSm Protein of Rift Valley Fever Virus Suppresses Virus-Induced Apoptosis (2007) (181)
- First field evidence for natural vertical transmission of West Nile virus in Culex univittatus complex mosquitoes from Rift Valley province, Kenya. (2000) (177)
- Identification of a new North American hantavirus that causes acute pulmonary insufficiency. (1995) (177)
- Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. (1997) (176)
- Hantavirus pulmonary syndrome: the first 100 US cases. (1996) (176)
- Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) (2004) (175)
- Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus Infection (2010) (168)
- Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. (1999) (166)
- Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis. (1991) (165)
- Interepidemic Rift Valley Fever Virus Seropositivity, Northeastern Kenya (2008) (165)
- Human infection with arenaviruses in the Americas. (2002) (165)
- Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. (1994) (164)
- Genome structure and variability of a virus causing hantavirus pulmonary syndrome. (1994) (164)
- Addressing emerging infectious disease threats; a prevention strategy for the United States : executive summary (1994) (161)
- Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. (1999) (158)
- Hantavirus pulmonary syndrome: the new American hemorrhagic fever. (2002) (156)
- Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. (1989) (154)
- A newly recognized virus associated with a fatal case of hantavirus pulmonary syndrome in Louisiana (1995) (153)
- Past, present, and future of arenavirus taxonomy (2015) (152)
- Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. (1999) (151)
- The phylogeny of New World (Tacaribe complex) arenaviruses. (1996) (151)
- Genetic Analysis of the Diversity and Origin of Hantaviruses in Peromyscus leucopus Mice in North America (1998) (150)
- Hantavirus Infection Induces the Expression of RANTES and IP-10 without Causing Increased Permeability in Human Lung Microvascular Endothelial Cells (2001) (148)
- Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. (1997) (147)
- Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator. (1986) (145)
- Glucan-induced enhancement of host resistance to selected infectious diseases (1980) (145)
- Taxonomy of the family Arenaviridae and the order Bunyavirales: update 2018 (2018) (145)
- Isolation of black creek canal virus, a new hantavirus from Sigmodon hispidus in Florida (1995) (144)
- Intravenous Ribavirin for Hantavirus Pulmonary Syndrome: Safety and Tolerance during 1 Year of Open-Label Experience (1998) (143)
- Long-term studies of hantavirus reservoir populations in the southwestern United States: rationale, potential, and methods. (1999) (142)
- An outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates, 1994-1995. (1997) (140)
- A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. (2001) (140)
- Search for the Ebola virus reservoir in Kikwit, Democratic Republic of the Congo: reflections on a vertebrate collection. (1999) (139)
- Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. (1999) (139)
- Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. (2001) (139)
- Naturally occurring Sin Nombre virus genetic reassortants. (1995) (138)
- Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. (2000) (137)
- Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. (1999) (137)
- Severe Acute Respiratory Syndrome Coronavirus 3a Protein Is a Viral Structural Protein (2005) (136)
- Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. (1997) (136)
- Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. (1999) (135)
- Exogenous ACE2 Expression Allows Refractory Cell Lines To Support Severe Acute Respiratory Syndrome Coronavirus Replication (2005) (135)
- Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor. (2006) (134)
- Diagnosis and Clinical Virology of Lassa Fever as Evaluated by Enzyme-Linked Immunosorbent Assay, Indirect Fluorescent-Antibody Test, and Virus Isolation (2000) (134)
- Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. (1989) (134)
- Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. (2011) (134)
- Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates (1992) (132)
- Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. (1997) (129)
- Genetic investigation of novel hantaviruses causing fatal HPS in Brazil (1999) (128)
- Ultrastructural characteristics of Sin Nombre virus, causative agent of hantavirus pulmonary syndrome (2005) (127)
- A longitudinal study of Junin virus activity in the rodent reservoir of Argentine hemorrhagic fever. (1992) (126)
- Hantaviruses and hantavirus pulmonary syndrome. (1994) (122)
- Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. (1994) (121)
- Apical Entry and Release of Severe Acute Respiratory Syndrome-Associated Coronavirus in Polarized Calu-3 Lung Epithelial Cells (2005) (119)
- Crimean‐Congo haemorrhagic fever: a seroepidemiological and tick survey in the Sultanate of Oman (2000) (118)
- Pathogenesis of a North American hantavirus, Black Creek Canal virus, in experimentally infected Sigmodon hispidus. (1998) (118)
- NSm and 78-Kilodalton Proteins of Rift Valley Fever Virus Are Nonessential for Viral Replication in Cell Culture (2006) (117)
- General aspects of the 1987 Rift Valley fever epidemic in Mauritania. (1989) (117)
- Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. (1997) (117)
- Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. (2001) (116)
- Pathogenesis of viral hemorrhagic fevers: Rift Valley fever and Lassa fever contrasted. (1989) (115)
- Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep. (1991) (114)
- Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain (1984) (114)
- Genetic reassortment among viruses causing hantavirus pulmonary syndrome. (1998) (111)
- Combined simian hemorrhagic fever and Ebola virus infection in cynomolgus monkeys. (1992) (110)
- Genetic and serologic analysis of Black Creek Canal virus and its association with human disease and Sigmodon hispidus infection. (1995) (109)
- Satellite imagery characterizes local animal reservoir populations of Sin Nombre virus in the southwestern United States (2002) (108)
- Role of the endothelium in viral hemorrhagic fevers (2002) (108)
- Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic. (1996) (107)
- Khabarovsk virus: a phylogenetically and serologically distinct hantavirus isolated from Microtus fortis trapped in far-east Russia. (1996) (106)
- Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. (1984) (106)
- Ecology and Epidemiology of Arenaviruses and Their Hosts (1993) (105)
- Direct genetic detection of Dobrava virus in Greek and Albanian patients with hemorrhagic fever with renal syndrome. (1996) (104)
- Taxonomy of the order Bunyavirales: second update 2018 (2019) (104)
- Outbreak of fatal illness among captive macaques in the Philippines caused by an Ebola-related filovirus. (1992) (103)
- Rift Valley Fever Virus Nonstructural Protein NSs Promotes Viral RNA Replication and Transcription in a Minigenome System (2005) (102)
- Hantavirus infection--southwestern United States: interim recommendations for risk reduction. Centers for Disease Control and Prevention. (1993) (101)
- Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. (1987) (101)
- Replication of dengue and junin viruses in cultured rabbit and human endothelial cells (1978) (101)
- Male determined accelerated autoimmune disease in BXSB mice: transfer by bone marrow and spleen cells. (1980) (100)
- NEUROVIRULENT TOSCANA VIRUS (A SANDFLY FEVER VIRUS) IN SWEDISH MAN AFTER VISIT TO PORTUGAL (1985) (99)
- Brief report: treatment of a laboratory-acquired Sabiá virus infection. (1995) (98)
- A survey of hantavirus antibody in small-mammal populations in selected United States National Parks. (1998) (98)
- Recombinant human monoclonal antibodies to Ebola virus. (1999) (96)
- Role of Actin Microfilaments in Black Creek Canal Virus Morphogenesis (1998) (95)
- Hantavirus pulmonary syndrome: an emerging infectious disease. (1993) (94)
- Complete genetic characterization and analysis of isolation of Sin Nombre virus (1995) (94)
- Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats. (1987) (92)
- Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay (1984) (91)
- Lymphocytic choriomeningitis virus. A neglected pathogen of man. (1992) (89)
- Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus (2012) (89)
- Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. (1999) (89)
- Prevalence of infection with Junin virus in rodent populations in the epidemic area of Argentine hemorrhagic fever. (1994) (89)
- Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. (1997) (89)
- Rift Valley Fever Virus NSs mRNA Is Transcribed from an Incoming Anti-Viral-Sense S RNA Segment (2005) (88)
- The incubation period of hantavirus pulmonary syndrome. (2000) (88)
- Lassa fever in Guinea: II. Distribution and prevalence of Lassa virus infection in small mammals. (2001) (87)
- Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions. (2007) (86)
- Rift Valley fever in rural northern Senegal: human risk factors and potential vectors. (1994) (86)
- Lymphocytic choriomeningitis virus--an old enemy up to new tricks. (2006) (86)
- Isolation and characterization of Whitewater Arroyo virus, a novel North American arenavirus. (1996) (84)
- Hantavirus transmission in the United States. (1997) (83)
- Experimental Rift Valley fever in rhesus macaques (2005) (83)
- Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha. (1989) (82)
- Life-threatening Cache Valley virus infection. (1997) (82)
- Severe Acute Respiratory Syndrome and the Innate Immune Responses: Modulation of Effector Cell Function without Productive Infection1 (2005) (82)
- Rift Valley fever among domestic animals in the recent West African outbreak. (1989) (82)
- Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Ebola and Marburg Viruses Using Recombinant Nucleoproteins (2001) (81)
- Venezuelan hemorrhagic fever: clinical and epidemiological studies of 165 cases. (1998) (81)
- Dual Functions of Rift Valley Fever Virus NSs Protein: Inhibition of Host mRNA Transcription and Post‐transcriptional Downregulation of Protein Kinase PKR (2009) (80)
- Sin Nombre virus glycoprotein trafficking. (2003) (79)
- Studies on the antigenic relationship among phleboviruses. (1982) (79)
- Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures. (1995) (78)
- Detection of Muerto Canyon virus RNA in peripheral blood mononuclear cells from patients with hantavirus pulmonary syndrome. (1994) (77)
- Hantavirus pulmonary syndrome in Florida: association with the newly identified Black Creek Canal virus. (1996) (75)
- Hemorrhagic fever in Cochabamba, Bolivia, 1971. (1974) (75)
- Junin virus activity in rodents from endemic and nonendemic loci in central Argentina. (1991) (75)
- Sin Nombre virus mRNA synthesis. (1996) (74)
- Black Creek Canal Virus infection in Sigmodon hispidus in southern Florida. (1998) (73)
- Evidence against person-to-person transmission of hantavirus to health care workers. (1996) (73)
- Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995. (1999) (73)
- Lymphocytic choriomeningitis virus: an unrecognized teratogenic pathogen. (1995) (73)
- Filoviruses as emerging pathogens (1994) (73)
- Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV (2007) (71)
- Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993: implications for emerging infectious diseases. (1996) (70)
- Genetic identification of a new Puumala virus strain causing severe hemorrhagic fever with renal syndrome in Germany. (1994) (70)
- Congenital lymphocytic choriomeningitis virus infection in twins (1993) (69)
- Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response (2005) (69)
- Natural rodent host associations of Guanarito and pirital viruses (Family Arenaviridae) in central Venezuela. (1999) (69)
- Junín Virus Pathogenesis and Virus Replication (2012) (69)
- Community ecology of small mammal populations in Panamá following an outbreak of Hantavirus pulmonary syndrome. (2004) (68)
- Postepidemic Analysis of Rift Valley Fever Virus Transmission in Northeastern Kenya: A Village Cohort Study (2011) (67)
- Serological Relationship of the Tacaribe Complex of Viruses to Lymphocytic Choriomeningitis Virus (1970) (66)
- Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein (2006) (66)
- Enzyme-linked immunosorbent assay for detection of antibodies to Rift Valley fever virus in ovine and bovine sera. (1987) (65)
- Patients infected with high-hazard viruses: scientific basis for infection control. (1996) (65)
- Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys. (2003) (65)
- New filovirus disease classification and nomenclature (2019) (63)
- Severe Rift Valley fever may present with a characteristic clinical syndrome. (2007) (62)
- Clinical case definitions for Argentine hemorrhagic fever. (1999) (61)
- Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (reston serotype) * * (2001) (60)
- Cross-neutralization of hantaviruses with immune sera from experimentally infected animals and from hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome patients. (1995) (60)
- Isolation and characterization of pirital virus, a newly discovered South American arenavirus. (1997) (60)
- Inbred rat strains mimic the disparate human response to rift valley fever virus infection (1982) (59)
- Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus. (2011) (58)
- Bilateral Entry and Release of Middle East Respiratory Syndrome Coronavirus Induces Profound Apoptosis of Human Bronchial Epithelial Cells (2013) (58)
- Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep. (2013) (57)
- Severe Acute Respiratory Syndrome Coronavirus Accessory Protein 6 Is a Virion-Associated Protein and Is Released from 6 Protein-Expressing Cells (2007) (56)
- Phylogenetic relationships among members of the genus Phlebovirus (Bunyaviridae) based on partial M segment sequence analyses. (2003) (56)
- Outbreak of Hantavirus Pulmonary Syndrome, Los Santos, Panama, 1999–2000 (2004) (55)
- Aerosol infection of rhesus macaques with Junin virus. (1992) (55)
- Characterization of Rift Valley Fever Virus Transcriptional Terminations (2007) (54)
- Natural nidality in Bolivian hemorrhagic fever and the systematics of the reservoir species. (2002) (54)
- Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters. (2009) (54)
- Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay (1984) (54)
- Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and Names (2014) (53)
- Localization of Hantaan viral envelope glycoproteins by monoclonal antibodies in renal tissues from patients with Korean hemorrhagic fever H. (1993) (51)
- Reemergence of Ebola virus in Africa. (1995) (51)
- Factors Associated with Severe Human Rift Valley Fever in Sangailu, Garissa County, Kenya (2015) (50)
- Viral determinants of virulence for Rift Valley fever (RVF) in rats. (1988) (50)
- Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials. (1986) (50)
- Experimental Argentine hemorrhagic fever in rhesus macaques: viral strain-dependent clinical response. (1985) (50)
- Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: evidence of a decreased risk of infection. (1997) (50)
- Marburg and Ebola--arming ourselves against the deadly filoviruses. (2005) (50)
- Seroepidemiological survey for antibodies to arboviruses in Greece (1990) (49)
- Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome. (2002) (49)
- Prospects for the control of Bolivian hemorrhagic fever. (1995) (49)
- Ribavirin Treatment of Toga-, Arena- and Bunyavirus Infections in Subhuman Primates and Other Laboratory Animal Species (1979) (49)
- Natural thymocytotoxic autoantibodies in autoimmune and normal mice. (1979) (49)
- Hantavirus pulmonary syndrome in the Americas. (1997) (48)
- Experimental infection of the cane mouse Zygodontomys brevicauda (family Muridae) with guanarito virus (Arenaviridae), the etiologic agent of Venezuelan hemorrhagic fever. (1999) (48)
- Effect of ribavirin and tributylribavirin on argentine hemorrhagic fever (Junin virus) in guinea pigs (1986) (48)
- Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs. (2008) (48)
- Hantavirus pulmonary syndrome (1996) (48)
- Differential Virological and Immunological Outcome of Severe Acute Respiratory Syndrome Coronavirus Infection in Susceptible and Resistant Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2 (2009) (47)
- Field studies on the epidemiology of Venezuelan hemorrhagic fever: implication of the cotton rat Sigmodon alstoni as the probable rodent reservoir. (1993) (47)
- Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep. (1980) (47)
- Pathogenesis of a phleboviral infection (Punta Toro virus) in golden Syrian hamsters (2005) (46)
- Experimental evaluation of rodent exclusion methods to reduce hantavirus transmission to humans in rural housing. (1997) (46)
- Infection of Macaca radiata with viruses of the tick-borne encephalitis group. (1992) (45)
- Severe Acute Respiratory Syndrome Coronavirus 3a Protein Is Released in Membranous Structures from 3a Protein-Expressing Cells and Infected Cells (2006) (45)
- Hantavirus pulmonary syndrome. (1995) (45)
- Viral hemorrhagic fevers and hantavirus infections in the Americas. (1998) (45)
- Development of a reverse transcription‐polymerase chain reaction assay for diagnosis of lymphocytic choriomeningitis virus infection and its use in a prospective surveillance study (1997) (44)
- Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine. (2011) (44)
- Isolation, genetic diversity, and geographic distribution of Bayou virus (Bunyaviridae: hantavirus). (1997) (44)
- Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humans. (1985) (44)
- Genetic characterization of a human isolate of Puumala hantavirus from France. (1995) (44)
- Detection of Rift Valley fever virus antigen by enzyme-linked immunosorbent assay (1983) (44)
- Hantaan virus infection in suckling mice: Virologic and pathologic correlates (1985) (44)
- Long-term disease surveillance in Bandundu region, Democratic Republic of the Congo: a model for early detection and prevention of Ebola hemorrhagic fever. (1999) (44)
- Hantavirus pulmonary syndrome in the rural area of Juquitiba, São Paulo metropolitan area, Brazil. (1997) (43)
- Hantavirus Pulmonary Syndrome and Newly Described Hantaviruses in the United States (1996) (43)
- Hantavirus and Arenavirus Antibodies in Persons with Occupational Rodent Exposure, North America (2007) (43)
- Isolation of a newly recognized Bunyamwera serogroup virus from a febrile human in Panama. (1988) (43)
- Virus‐specific factors in experimental Argentine hemorrhagic fever in rhesus macaques (1987) (43)
- Hemostatic derangement produced by Rift Valley fever virus in rhesus monkeys. (1989) (43)
- The S Segment of Punta Toro Virus (Bunyaviridae, Phlebovirus) Is a Major Determinant of Lethality in the Syrian Hamster and Codes for a Type I Interferon Antagonist (2006) (43)
- Assessment of person-to-person transmission of hantavirus pulmonary syndrome in a Chilean hospital setting. (1998) (42)
- SEROLOGICAL RELATION BETWEEN RIFT VALLEY FEVER VIRUS AND VIRUSES OF PHLEBOTOMUS FEVER SEROGROUP (1980) (42)
- The gerbil, Meriones unguiculatus, a model for Rift Valley fever viral encephalitis (2005) (42)
- Rift Valley Fever Virus L Protein Forms a Biologically Active Oligomer (2009) (42)
- Blocking of Exchange Proteins Directly Activated by cAMP Leads to Reduced Replication of Middle East Respiratory Syndrome Coronavirus (2014) (41)
- Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves. (2013) (41)
- The spread of Rift Valley fever and approaches to its control. (1982) (40)
- Transmission of Black Creek Canal virus between cotton rats (2000) (40)
- Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA (2010) (40)
- Treatment of Junin Virus‐Infected Guinea Pigs With Immune Serum: Development of Late Neurological Disease (1986) (39)
- Evaluation of the magnitude of the 1993 hantavirus outbreak in the southwestern United States. (1995) (38)
- A Rift Valley Fever Vaccine Trial. 1. Side Effects and Serologic Response Over a Six-Month Follow-Up (1982) (38)
- Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. (1999) (38)
- Rift Valley fever: a sero-epidemiological survey among pregnant women in Mozambique (1987) (37)
- Laboratory management of agents associated with hantavirus pulmonary syndrome; interim biosafety guidelines (1994) (37)
- Filovirus diseases. (1999) (36)
- Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates. (2016) (36)
- Hantavirus pulmonary syndrome in pregnancy. (1999) (35)
- Serologic survey among hospital and health center workers during the Ebola hemorrhagic fever outbreak in Kikwit, Democratic Republic of the Congo, 1995. (1999) (34)
- Rapid diagnosis of Rift Valley fever: a comparison of methods for the direct detection of viral antigen in human sera. (1989) (34)
- Infection of inbred rat strains with Rift Valley fever virus: development of a congenic resistant strain and observations on age-dependence of resistance. (1991) (33)
- Radioimmunoassay for antibody to hepatitis B surface antigen shows transmission of hepatitis B virus among household contacts. (1976) (32)
- Viral strain dependent differences in experimental Argentine hemorrhagic fever (Junin virus) infection of guinea pigs. (1988) (31)
- Sin nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome. (2000) (31)
- Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep. (2014) (31)
- Oliveros virus: a novel arenavirus from Argentina. (1996) (31)
- Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans. (2016) (31)
- Recombinant human interferon-γ modulates rift valley fever virus infection in the rhesus monkey (1991) (31)
- Prevalence of antibodies to arenaviruses in rodents from the southern and western United States: evidence for an arenavirus associated with the genus Neotoma. (1996) (30)
- Comparison of in vitro and in vivo systems for propagation of Rift Valley fever virus from clinical specimens. (1989) (29)
- Characterization of Oliveros virus, a new member of the Tacaribe complex (Arenaviridae: Arenavirus). (1996) (29)
- Formation and characterization of an intertypic lymphocytic choriomeningitis recombinant virus. (1980) (29)
- MONOCLONAL ANTIBODIES TO IDENTIFY ZINGA VIRUS AS RIFT VALLEY FEVER VIRUS (1983) (29)
- Infectious diseases from nature : mechanisms of viral emergence and persistence (2005) (28)
- Hantavirus pulmonary syndrome in the State of São Paulo, Brazil, 1993-1998. (2001) (28)
- Differences in the prevalence of hepatitis B antigen and antibody among Panamanian Indian populations. (1973) (28)
- A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injection. (1985) (28)
- Protection of guinea pigs against experimental Argentine hemorrhagic fever by purified human IgG: importance of elimination of infected cells. (1990) (28)
- Mild hantaviral disease caused by sin Nombre virus in a four-year-old child. (1995) (27)
- Adjuvant activity of a novel metabolizable lipid emulsion with inactivated viral vaccines. (1980) (27)
- Marburg and Ebola Virus Hemorrhagic Fevers (2010) (26)
- Serological tests for detecting Rift Valley fever viral antibodies in sheep from the Nile Delta (1986) (25)
- Hemorrhagic Fever Viruses (1984) (25)
- The Nucleocapsid Protein of Rift Valley Fever Virus Is a Potent Human CD8+ T Cell Antigen and Elicits Memory Responses (2013) (25)
- Detection and sequence confirmation of Sin Nombre virus RNA in paraffin-embedded human tissues using one-step RT-PCR. (1995) (23)
- Evidence against infection with hantaviruses among forest and park workers in the southwestern United States. (1996) (23)
- Sand fly fever-Naples infection in Egypt. (1987) (22)
- Rift Valley Fever (2011) (22)
- Pathogenesis of Pichinde virus infection in strain 13 guinea pigs: an immunocytochemical, virologic, and clinical chemistry study. (1993) (22)
- Effect of immunosuppression on experimental Argentine hemorrhagic fever in guinea pigs (1985) (22)
- A survey for antibodies to Lassa virus among health workers in Nigeria. (1997) (22)
- Congenital lymphocytic choriomeningitis virus infection. (1996) (21)
- Seroprevalence of antibodies to hantavirus in health care workers and other residents of southern Argentina. (1998) (21)
- RIG-I Enhanced Interferon Independent Apoptosis upon Junin Virus Infection (2014) (21)
- Venezuelan equine encephalitis‐specific immunoglobulin responses: Live attenuated TC‐83 versus inactivated C‐84 vaccine (1992) (20)
- Hantavirus infection in Taiwan: The experience of a geographically unique area (2000) (20)
- Venezuelan equine encephalomyelitis virus infection in and transmission by the tick Amblyomma cajennense (Arachnida: Ixodidae). (1991) (20)
- Recombinant human interferon-gamma modulates Rift Valley fever virus infection in the rhesus monkey. (1991) (19)
- Possibility and Challenges of Conversion of Current Virus Species Names to Linnaean Binomials. (2016) (19)
- Filovirus contamination of cell cultures. (1992) (19)
- California Encephalitis, Hantavirus Pulmonary Syndrome, and Bunyavirid Hemorrhagic Fevers (2010) (19)
- Isolation of the Rift Valley fever virus by inoculation into Aedes pseudoscutellaris cells: comparison with other diagnostic methods. (1989) (19)
- Hantavirus pulmonary syndrome in California: report of two cases and investigation. (1994) (19)
- Rift Valley fever infection of rhesus monkeys: implications for rapid diagnosis of human disease. (1989) (18)
- Serum immunoglobulin levels in Australia antigen positive and Australia antigen negative hepatitis. (1972) (18)
- IgM levels and IgM-mediated immune responses in patients with acute hepatitis A, acute hepatitis B and chronic HB antigenaemia. (1976) (18)
- Virus Hunter: Thirty Years of Battling Hot Viruses Around the World (1997) (17)
- Synergistic Inhibition of Sars-Coronavirus Replication by Type I and Type II IFN (2006) (17)
- Diseases of the central nervous system caused by lymphocytic choriomeningitis virus and other arenaviruses. (2014) (16)
- A rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up. (1982) (16)
- Cytolysis of Junin infected target cells by immune guinea pig spleen cells. (1986) (15)
- Behavior of Machupo and Latino Viruses in Calomys callosus from Two Geographic Areas of Bolivia (1973) (15)
- Emerging infections: lessons from the viral hemorrhagic fevers. (2006) (15)
- Are Hemorrhagic Fever Viruses Practical Agents for Biological Terrorism (2000) (15)
- Endothelial cell permeability and adherens junction disruption induced by junín virus infection. (2014) (15)
- Cis-acting elements in the antigenomic promoter of Nipah virus. (2007) (15)
- Viral Hemorrhagic Fever (1986) (15)
- Fatal hantavirus pulmonary syndrome in an adolescent. (1995) (15)
- Lymphocytic Choriomeningitis Virus, Lassa Virus, and the South American Hemorrhagic Fevers (2010) (15)
- An outbreak of coxsackievirus B infection followed by one case of diabetes mellitus. (1985) (15)
- International Colloquium on Ebola Virus Research: summary report. (1997) (15)
- Two cases of hemorrhagic fever with renal syndrome in northern Greece. (1984) (14)
- Hantaviral infections of rodents: possible scenarios (2009) (13)
- Emerging infections--Ebola and other filoviruses. (1996) (13)
- 13 Ebola virus: where does it come from and where is it going? (1998) (13)
- Infection of Cebus monkeys with Junín virus. (1985) (13)
- Susceptibility of Inbred Syrian Golden Hamsters (Mesocricetus auratus) to Lethal Disease by Lymphocytic Choriomeningitis Virus (1987) (12)
- Short report: isolation and partial characterization of a Puumala virus from a human case of nephropathia epidemica in France. (1995) (11)
- Heterogeneity of Junin virus strains (2005) (11)
- Antibody-dependent cellular cytotoxicity against murine leukemia viral antigens: studies with human lymphoblastoid cell lines and human peripheral lymphocytes as effector cells comparing rabbit, goat, and mouse antisera. (1977) (11)
- Familial clustering of hepatitis B surface antigen among Panamanian Indians. (1975) (11)
- CHAPTER 68 – Arenavirus Infections (2011) (10)
- Potential for autoimmune pathogenesis of Rift Valley Fever virus retinitis. (2013) (10)
- Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development (2005) (10)
- Experimental infection of Phlebotomus papatasi with sand fly fever Sicilian virus. (1988) (10)
- Virologic investigation of a case of suspected haemorrhagic fever. (1994) (10)
- The extended horizons of Rift Valley fever: current and projected immunogens. (1980) (10)
- CHAPTER 67 – Overview of Viral Hemorrhagic Fevers (2011) (9)
- 1 REGULATION OF IRF-3 DEPENDENT INNATE IMMUNITY BY THE PAPAIN-LIKE PROTEASE DOMAIN OF THE SARS CORONAVIRUS (2007) (9)
- Hemorrhagic fever with renal syndrome--a clinical perspective. (1985) (9)
- Chapter 65 – Overview of Viral Hemorrhagic Fevers (2006) (9)
- Correction for Osterholm et al., Transmission of Ebola Viruses: What We Know and What We Do Not Know (2015) (8)
- Three-Dimensional Human Bronchial-Tracheal Epithelial Tissue-Like Assemblies (TLAs) as Hosts for Severe Acute Respiratory Syndrome (SARS)-CoV Infection (2006) (8)
- Rift Valley fever surveillance in mobile sheep flocks in the Nile Delta. (1986) (8)
- Susceptibility and resistance of inbred strains of Syrian golden hamsters (Mesocricetus auratus) to wasting disease caused by lymphocytic choriomeningitis virus: pathogenesis of lethal and non-lethal infections. (1988) (8)
- Antigenic Components of Punta Toro Virus (1981) (7)
- Lessons learned from the hantaviruses and other hemorrhagic fever viruses. (1996) (7)
- Hemorrhagic Fevers: How They Wax and Wane (1998) (7)
- Assessment of an rDNA probe filter hybridization assay for the detection of Rift Valley fever virus RNA in human serum samples from the Mauritanian epidemic. (1989) (7)
- Immunosuppression-induced susceptibility of inbred hamsters (Mesocricetus auratus) to lethal-disease by lymphocytic choriomeningitis virus infection (2005) (7)
- Actions of complement on Junin virus. (1989) (7)
- Evaluation of cotton rats as a model for severe acute respiratory syndrome. (2008) (7)
- Differential effects of propranolol on lymphocyte rosette formation and response to plant mitogens. (1978) (7)
- HANTA VIRUSES AND THEIR RODENT RESERVOIRS IN THE UNITED STATES (1994) (7)
- Delayed type-hypersensitivity response of inbred strains of Syrian golden hamsters (Mesocricetus auratus) to lethal or non-lethal lymphocytic choriomeningitis virus (LCMV) infections. (1989) (7)
- Epidemiology of hepatitis B antigen in Panama. (1973) (6)
- New challenges to health: The viruses in our past, the viruses in our future (2001) (6)
- Rapid detection of Rift Valley fever antigen in the serum of infected lambs. (1989) (6)
- Hantaviruses in the United States. (1996) (6)
- Differentiation of a human monocytic cell line associated with increased production of Rift Valley fever virus by infected cells (1987) (6)
- Evolutionary biology of a Lassa virus complex (2005) (5)
- Mapping a Major Gene for Resistance to Rift Valley Fever Virus in Laboratory Rats. (2015) (5)
- Chapter 67 – Bunyaviral Fevers: Rift Valley Fever and Crimean-Congo Hemorrhagic Fever (2006) (5)
- Immune response of steers, goats and sheep to inactivated Rift Valley Fever vaccine. (1979) (5)
- Chapter 66 – Arenavirus Infections (2006) (5)
- A serological survey of Rift Valley fever antibodies in the northern Sinai. (1982) (5)
- Emerging zoonoses. (1998) (4)
- Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile (2020) (4)
- Resolved: emerging infections of humans can be controlled by ecological interventions. (2010) (4)
- Seven murine cell lines with properties of macrophages. (1981) (4)
- Antigenic subtypes of hepatitis B antigen in Panama. (1974) (4)
- CHAPTER 71 – Hantavirus Infections (2011) (4)
- Lipopolysaccharide inhibits the production of lymphocytic choriomeningitis virus in a human monocytic cell line. (1993) (4)
- Genetic Identificationo f a HantavirusA ssociated with an Outbreako f Acute RespiratoryI llness (1993) (4)
- The epidemiology of hepatitis B antigen and antibody among Panamanian Cuna Indians. (1975) (3)
- Correction: Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA (2010) (3)
- Forty Years with Emerging Viruses. (2014) (3)
- Hepatitis B in families. (1982) (3)
- Aerosols from insect control measures show dangers of bioterrorism. (2003) (3)
- Viral Hemorrhagic Fevers as Agents of Bioterrorism (2010) (3)
- Pathology and Pathogenesis of Lassa Fever: Novel Immunohistochemical Findings in Fatal Cases and Clinico-pathologic Correlation. (2021) (2)
- Ebola and hantaviruses. (1997) (2)
- Viral hemorrhagic fevers (2021) (2)
- Corrigendum to ''Genetic characterization of a human isolate of Puumala hantavirus from France'' (Virus Research 38 (1995) 279-289) (2001) (2)
- Isolation of Rift Valley fever virus from human peripheral blood mononuclear cells: Mauritanian epidemic. (1989) (2)
- COMMUNITIES OF THE SOUTHWESTERN UNITED STATES (1997) (2)
- CHAPTER 73 – Filovirus Infections (2011) (2)
- Serological evidence of endemic Zinga virus and Rift Valley Fever virus in Central African Republic. (1983) (2)
- Disparate response of monozygotic twins to hepatitis B virus infection. (1977) (2)
- Metabolism of platelet‐activating factor in neutrophils isolated from Pichinde virus–infected guinea pigs (1992) (2)
- Lymphocytic choriomeningitis virus (LCMV): a human teratogen (1993) (1)
- Distinguishing Tropical Infectious Diseases from Bioterrorism (2006) (1)
- Ebola Virus Hemorrhagic Fever, Zaire, 1995: an Ultrastructural Study (1997) (1)
- [Geographic distribution of hematologic elements in Central African countries: distribution of the ABO blood group system]. (1987) (1)
- Other Viruses and Emerging Viruses of Concern (2002) (1)
- Factors Associated with Severe Human Rift (2015) (1)
- Past, present, and future of arenavirus taxonomy (2015) (1)
- Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease (2022) (1)
- Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol (2000) (1)
- Chapter 68 – Hantavirus Infections (2006) (1)
- Global Microbial Threats Emerging Infections Ebola and Other Filoviruses (2005) (0)
- RIFT VALLEY FEVER VIRAL ENCEPHALITIS IN THE GERBIL: ULTRASTRUCTURAL AND IMMUNOCYTOCHEMICAL CORRELATIONS (1990) (0)
- RIFT VALLEY FEVER VIRAL ENCEPHALITIS IN THE GERBIL: 42 (1989) (0)
- Rift Valley Fever Virus NSs mRNA Is Transcribed from an Incoming Anti-Viral-Sense S RNA Segment propagated in Vero E6 cells using anti-RVFV mouse (2005) (0)
- New filovirus disease classification and nomenclature (2019) (0)
- Blocking of Exchange Proteins Directly Activated by cAMP (Epac) Leads to Reduced (2014) (0)
- Q Detection of Rift Valley Fever Virus Antigen b nzyme-Linked Immunosorbent Assay (0)
- In bred Syrian Golden Hamsters (Mesocricetus auratus) to Lethal Disease by Lymphocytic Choriomeningitis Virus (42541 ) (1987) (0)
- 1 Outbreaks of Ebolavirus Hemorrhagic Fever Virus Year ( s ) Location Cases ( % Case Fatality ) Epidemiology Remarks (2014) (0)
- Role(s) of Pulmonary Macrophage and Dendritic Cells in SARS-CoV-Induced Host Inflammatory Responses: An in vitro Model. (43.39) (2007) (0)
- Experiences of a Virus Hunter (2000) (0)
- Simultaneous Genomic Detection of Multiple Enteric Bacterial and Viral Pathogens, Including SARS-CoV and RVFV (2004) (0)
- Staphylococcus aureus and Escherichia hermanii in Diabetes Patient (2004) (0)
- Chapter 70 – Filovirus Infections (2006) (0)
- HANTAVIRUS PULMONARY SYNDROME IN GERMANY. AUTHORS'S REPLIES (1996) (0)
- epistatic interactions with the E1-E2 glycoprotein and NS3-4A enzyme complexes. 2 (2009) (0)
- Development of a Live Attenuated Vaccine against Rift Valley Fever (1985) (0)
- Replication ofDengueandJuninViruses inCultured Rabbit andHumanEndothelial Cellst (1978) (0)
- Serological Tests forDetecting Rift Valley FeverViral Antibodies in SheepfromtheNileDelta (1986) (0)
- Inbred Rat Strains Mimic the Disparate ce Human Response to Rift Valley Fever Virus C q Infection (0)
- Rift Valley fever MP-12 vaccine elicits an early protective immune response in mice. (2022) (0)
- THE JOURNAL OF INFECTIOUS DISEASES (0)
- PATFERNS OF ASSOCIATION WITH HOST AND HABITAT: ANTIBODY REACTIVE WITH SIN NOMBRE VIRUS IN SMALL MAMMALS IN THE MAJOR BIOTIC COMMUNITIES OF THE SOUTHWESTERN UNITED STATES (2006) (0)
- SHORT COMMUNICATION Oliveros Virus: A Novel Arenavirus from Argentina (1996) (0)
- Cell transfer studies in autoimmune bxsb mice. Abstr. (1979) (0)
- Distinguishing Tropical Infectious Diseases from Bioterrorism (2011) (0)
- neutralizing antibody and Lassa virus strain. cynomolgus monkeys: importance of Passive antibody therapy of Lassa fever in (2013) (0)
- Effect ofImmunosuppression onExperimental Argentine Hemorrhagic FeverinGuinea Pigs (1985) (0)
- The seroepidemiology of reovirus, coxsackievirus infections among Panamanian Indian children. (1976) (0)
- Zoonoses and Vector-Borne Diseases (2008) (0)
- [Rift valley fever: propagation and methods of control]. (1982) (0)
- Results of bivariate analysis to determine significant relative odds of high RVF disease severity according to demographic data, clinical signs, symptoms, and exposure factors. (2015) (0)
- Detection ofRift Valley FeverVirus Antigen byEnzyme- Linked Immunosorbent Assay (1983) (0)
- Pathogenesis of a phleboviral infection (Punto Toro virus) in golden syrian hamsters (1988) (0)
- afety and immunogenicity of a mutagenized , live attenuated Rift alley fever vaccine , MP-12 , in a Phase 1 dose escalation and route omparison study in humans (2015) (0)
- Afghanistan and Pakistan : human rights reports (2012) (0)
- [New findings on Junin virus infection in rodents inside and outside the endemic area of hemorrhagic fever in Argentina]. (1991) (0)
- Typical peri-domestic landscape in the Sangailu area of Kenya. (2015) (0)
- Genetic variation among lassa and lassa related arenaviruses from different African origins (1985) (0)
- Rift Valley Fever Virus L Protein Forms a Biologically Active Oligomer (cid:1) (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Clarence J. Peters?
Clarence J. Peters is affiliated with the following schools:
